BEFOTERTINIB
UNII 0XT2CPR891

Substance Identification & Data

This profile provides standardized clinical and technical data for Befotertinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0XT2CPR891.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1835667-63-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

0XT2CPR891

CAS Registry Number

1835667-63-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BEFOTERTINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C29H32F3N7O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

USOCZVZOXKTJTI-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C175747

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

130412842

Unique identification number in the NCBI database of chemical substances.

INN ID

11357

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(C(F)(F)F)n1cc(c2c1cccc2)-c3nc(Nc4c(OC)cc(c(c4)NC(C=C)=O)N(CCN(C)C)C)ncc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Befotertinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.